Aurinia Pharmaceuticals | ARS: Annual Report to Security Holders
Aurinia Pharmaceuticals | DEFA14A: Others
Aurinia Pharmaceuticals | DEF 14A: Definitive information statements
Aurinia Pharmaceuticals | 10-Q: Quarterly report
Aurinia Pharmaceuticals | 8-K: AURINIA PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATIONAL RESULTS
Aurinia Pharmaceuticals | 10-K/A: Annual report (Amendment)
Aurinia Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chin Kyu Huh(5.2%),ILJIN SNT Co., Ltd.(4.4%), etc.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Greenleaf Peter
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Donley Matthew Maxwell
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Miller Joseph M
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Habig Scott Michael
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Stephen P.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Knappertz Volker
Aurinia Pharmaceuticals | 8-K: Current report
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Knappertz Volker
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Habig Scott Michael
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Donley Matthew Maxwell
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Stephen P.
Aurinia Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Miller Joseph M
Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Robertson Stephen P.
No Data